|
Calcifidol Therapy in Men with Cancer Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Calcifidol Therapy in Men with Cancer conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Calcifidol Therapy in Men with Cancer Clinical research trials and Calcifidol Therapy in Men with Cancer healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Calcifidol Therapy in Men with Cancer. Calcifidol Therapy in Men with Cancer Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Calcifidol Therapy in Men with Cancer clinical trial. Test subjects typically receive the most effective healthcare possible for their Calcifidol Therapy in Men with Cancer condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Calcifidol Therapy in Men with Cancer  Calcifidol Therapy in Men with Cancer
Calcifidol Therapy in Men with Cancer
For Condition: Prostate Cancer
Status: Recruiting
Sponsor(s): Department of Veterans Affairs Medical Research Service ,
Synopsis: Prostate cancer is a common occurrence in the aging population, with one in ten men destined to develop the disease. 40% of patients with prostate cancer experience a recurrence after definitive treatment. This study addresses the as-yet unresolved problem of the optimal management of early recurrence as manifested by increase in the accepted marker for this disease, PSA. Vitamin D, an agent with cell-differentiating properties, has been shown to inhibit angiogenesis and cause differentiation of prostate cancer cells in the laboratory and to affect PSA favorably in clinical studies of patients with advanced prostate cancer. This study will assess the effects of vitamin D in patients with sub-clinical biochemical relapses of prostate cancer as indicated by rising PSA but low tumor burdens, with the potential for developing an approach to this problem that will delay or prevent progression.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: Patients will be males with three successive rises in PSA after achieving a nadir post-definitive therapy. The following criteria must be met: pathologically confirmed prostate cancer, completion of definitive treatment in the form of local external beam radiation or definitive surgery and three successive rises in PSA with no clinical evidence of disease.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
GarySchwartz, ,
VAMC Miami, FL *Recruiting*
Miami, Florida, 33125
United States
Recruiting Gustavo Godoy 305-324-3179
Additional Information:
Study ID Numbers: ONCO-09-99S;
Study Start Date: October 1999
Record last reviewed: June 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00018538
Other Prostate Cancer Studies:
1. Treatment Decision Intervention for Veterans with Prostate Cancer
2. Clinical Trial for Prostate Cancer
3. Phase I Study of Weekly Intravenous PS-341 Plus Mitoxantrone
4. PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
5. Phase I Study of SU006668 in Patients With Advanced Solid Tumors
Related Studies:
Other Prostate Cancer Clinical Trials
Other Florida Clinical Trials
Other Miami Clinical Trials
Calcifidol Therapy in Men with Cancer
|
|
|
|
|
|
|
|
